Provided by Tiger Trade Technology Pte. Ltd.

GeneDx Holdings

57.09
-4.2600-6.94%
Post-market: 57.090.00000.00%19:47 EDT
Volume:1.16M
Turnover:67.37M
Market Cap:1.67B
PE:-77.79
High:61.12
Open:61.12
Low:55.18
Close:61.35
52wk High:170.87
52wk Low:55.17
Shares:29.29M
Float Shares:19.94M
Volume Ratio:1.77
T/O Rate:5.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7339
EPS(LYR):-0.7339
ROE:-7.60%
ROA:-1.55%
PB:5.43
PE(LYR):-77.79

Loading ...

GeneDx Holdings Corp : Jefferies Raises Target Price to $150 From $120

THOMSON REUTERS
·
Oct 29, 2025

BUZZ-GeneDx rises after Q3 results beat market estimates

Reuters
·
Oct 29, 2025

Stock Track | GeneDx Holdings Soars 5.43% on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Oct 29, 2025

Stock Track | GeneDx Plummets 6.63% Despite Strong Q3 Results as Company Files for Mixed Shelf Offering

Stock Track
·
Oct 28, 2025

GeneDx Holdings Corp reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Oct 28, 2025

GeneDx Shares up 3.3% After Q3 Results Beat, Annual Revenue Forecast Lift

THOMSON REUTERS
·
Oct 28, 2025

BUZZ-Check Point climbs as Q3 earnings beat forecasts

Reuters
·
Oct 28, 2025

ADVISORY-Alerts on dated news on GeneDx exiting two businesses withdrawn

Reuters
·
Oct 28, 2025

BRIEF-GeneDx Holdings Corp Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
Oct 28, 2025

GeneDx Holdings Corp Says in Addition, Offering of Class a Common Stock of up to $100 Mln

THOMSON REUTERS
·
Oct 28, 2025

GeneDx Holdings Corp - to Exit Reproductive and Somatic Tumor Testing Businesses - SEC Filing

THOMSON REUTERS
·
Oct 28, 2025

GUIDANCE: (WGS) GeneDx Expects Full Year 2025 Revenue Range $425M - $428M, vs. FactSet Est of $411.7M

MT Newswires Live
·
Oct 28, 2025

GeneDx Shares Rise 11.7% Premarket After Q3 Results Beat, Co Lifts Annual Revenue Outlook

THOMSON REUTERS
·
Oct 28, 2025

Stock Track | GeneDx Holdings Soars 6.41% Pre-Market on Strong Q3 Results, Revenue Beats Estimates

Stock Track
·
Oct 28, 2025

Stock Track | GeneDx Holdings Soars 6.41% Pre-market on Strong Q3 Revenue Beat

Stock Track
·
Oct 28, 2025

GeneDx Hldgs Q3 Adj. EPS $0.51 Beats $0.42 Estimate, Sales $116.743M Beat $104.670M Estimate

Benzinga
·
Oct 28, 2025

BRIEF-GeneDx Q3 Revenue USD 116.7 Million Vs. IBES Estimate USD 104.1 Million

Reuters
·
Oct 28, 2025

GeneDx - Raised FY Revenue Guidance to Between $425 and $428 Mln

THOMSON REUTERS
·
Oct 28, 2025

GeneDx Q3 Revenue USD 116.7 Million VS. Ibes Estimate USD 104.1 Million

THOMSON REUTERS
·
Oct 28, 2025

GeneDx Q3 Adjusted EPS USD 0.49 VS. Ibes Estimate USD 0.39

THOMSON REUTERS
·
Oct 28, 2025